768P Survival and benefit of adjuvant chemotherapy (ACT) by circulating tumor DNA (ctDNA)-based pretreatment genomic profile and postoperative molecular residual disease (MRD) in resectable colorectal oligometastases (CRM): PRECISION, a prospective multicenter studyS. Kobayashi, Yoshitsugu Nakamura, Akio Shiomi et al.|Annals of Oncology|2025Cited by 1